Deal-Making
GigaGen teams with NCI to develop oncology drug candidate
Deal MakingGigaGen teams with NCI to develop oncology drug candidateGigaGen teams with NCI to develop oncology drug candidate
GigaGen has partnered with the NCI to advance development of its anti-CTLA-4 antibody drug candidate for cancer, GIGA-564.